SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-037647
Filing Date
2021-11-12
Accepted
2021-11-12 16:11:14
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10030380_10q.htm   iXBRL 10-Q 830031
2 EXHIBIT 31.1 brhc10030380_31-1.htm EX-31.1 10440
3 EXHIBIT 31.2 brhc10030380_31-2.htm EX-31.2 10408
4 EXHIBIT 32.1 brhc10030380_32-1.htm EX-32.1 4662
5 EXHIBIT 32.2 brhc10030380_32-2.htm EX-32.2 4608
  Complete submission text file 0001140361-21-037647.txt   4325476

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aryd-20210930.xsd EX-101.SCH 39701
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aryd-20210930_cal.xml EX-101.CAL 21613
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aryd-20210930_def.xml EX-101.DEF 228259
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aryd-20210930_lab.xml EX-101.LAB 401521
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aryd-20210930_pre.xml EX-101.PRE 289830
11 EXTRACTED XBRL INSTANCE DOCUMENT brhc10030380_10q_htm.xml XML 569001
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 212-284-2300
ARYA Sciences Acquisition Corp IV (Filer) CIK: 0001838821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40122 | Film No.: 211403565
SIC: 2836 Biological Products, (No Diagnostic Substances)